Hyundai has gained more US market share this decade than any carmaker
THE SO WHAT
Hyundai’s $26B through 2028 to localize at least 80% of US sales—and already hitting ~80% in Europe—shows supply chain resilience and local content are now core go-to-market levers. Any hardware business selling into regulated or politically sensitive markets should be stress-testing localization and nearshoring options on a 3–5 year horizon.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechSurfshark adds category-based web filtering to its post-quantum Dausos protocol
Post-quantum VPN plus on-tunnel filtering is a preview of where network security is going—privacy tools bundling more policy enforcement at the edge. If you run distributed or remote-heavy teams, expect user devices and clients to carry more of the filtering logic instead of central appliances.
Deep & Emerging TechChina’s data centres will reportedly use more power than South Korea by 2030
A jump from 479 TWh to 774 TWh forecast by 2030 means Chinese data centers alone will rival mid-sized nations’ entire grids—compute planning is now energy planning. If you depend on Chinese cloud or colocated infra, add power pricing, grid constraints, and carbon policy to your long-term capacity assumptions.
Deep & Emerging TechLockheed’s Pricey F-35 Sees 10% Cost Jump for Needed Upgrades
A ~$51B, 10% cost increase on the F-35 driven by software, readiness, spares, and engine power is a reminder that complex systems’ real bill arrives in upgrades and sustainment. If you build long-lived platforms—defense or not—treat software modernization and parts logistics as first-class P&L lines, not afterthoughts.
Sam Altman's longevity startup is upping the dose in an Alzheimer's drug trial after a lackluster first round
Upping the dose after a weak initial readout is standard biotech iteration, but it underlines how far longevity narratives are from clinical reality in Alzheimer’s. Operators should treat high-profile backers as capital signals, not efficacy proof—wait for phase data before anchoring any strategy on these therapies.